Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread of HIV. Read More
Emory scientists have adapted an antiviral enzyme from bacteria called Cas9 into an instrument for inhibiting hepatitis C virus in human cells. Read More
A University of Colorado Boulder and North Carolina State University-led team has produced the first atlas of airborne microbes across the continental U.S., a feat that has implications for better understanding health and disease in humans, animals and crops. Read More
As the focus of the Ebola issue shifts from management to recovery and prevention, an array of post-infection effects have cropped up in survivors of the virus. Vision and hearing problems have resulted from infection with the Ebola virus, and researchers are now faced with the task of determin... Read More
This episode: Bacterial ghosts could make good vaccines for different things!
(9.8 MB, 10.7 minutes)
About eight percent of human DNA is viral: it consists of retroviral genomes produced by infections that occurred many years ago. These endogenous retroviruses are passed from parent to child in our DNA. Some of these viral genomes are activated for a brief time during human embryogenesis, sugge... Read More
PROVIDENCE, R.I. [Brown University] -- A new study provides evidence from lab experiments that a drug already used in people to fight tapeworms might also prove effective against strains of the superbug MRSA, which kills thousands of people a year in the United States. Read More
Household pets can transmit infection to people, especially those with weak immune systems, young children, pregnant women and seniors, according to an article in CMAJ (Canadian Medical Association Journal). Health care providers and pet owners should be aware of this risk to prevent illness in ... Read More
Come join us and be a part of the online audience at ASM Live, the live internet talk show of asm2015 highlighting various sessions and presentations at the 115th Meeting of the American Society for Microbiology.
Microbiologists from selected talks will sit down and discuss their research in ... Read More
Now about the term Talmudic.
A new study implicates bacteria that normally live in the urinary tract as the cause of death of some lung transplant patients. Read More
First of the three videos related to research article appearing in Lab on a Chip. I. H. Riedel-Kruse et al "Design, Engineering and Utility of Biotic Games". Read the article by clicking "source" above.
From the abstract:
Games are a significant and defining part of human culture, and thei... Read More
Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Diseases and available online. The trends raise serious concerns about th... Read More
The Ethiopian Society for Microbiology (ESM) has pledged that it would put relentless efforts in advancing microbiological sciences through conducting various scientific researches on molecular science and microbiology Read More
A team of French clinicians has diagnosed the first case of rabies in that country since 2003. Only 20 cases of human rabies had been diagnosed in France between 1970 and 2003. Moreover, the patient was unaware of having been bitten. So it is not surprising that that diagnosis was not suggested ... Read More
Though western diets and modern-day hygiene have wiped a few dozen species right out of our digestive tracts, "it's not clear if more diversity in the microbiome is healthier." -- M. Gloria Dominguez-Bello, New York University School of Medicine. Read More
University at Buffalo researchers have discovered a way to easily and effectively fasten proteins to nanoparticles by simply mixing them together. The biotechnology model is described in the journal Nature Chemistry. Read More
The University of Wisconsin researcher who’s worked to develop a vaccine for Ebola said Monday that the vaccine has shown promising results and could even enter the clinical trial phrase in two years. Read More